What question did this study set out to answer?

To compare the effectiveness of two sizes of trisacryl gelatin microspheres as embolic agents in prostatic artery embolization.

February 25, 2026Open Access

Single-center retrospective comparative study of 40–120 μm versus 100-300 μm trisacryl gelatin microspheres as the main embolic agents for prostatic artery embolization

Puntos clave

To compare the effectiveness of two sizes of trisacryl gelatin microspheres as embolic agents in prostatic artery embolization.
Retrospective comparison of two sizes of trisacryl gelatin microspheres (40–120 μm vs 100-300 μm)
Focus on clinical application in prostatic artery embolization
Analysis of potential implications for choosing embolic materials
This is the first systematic comparison of these two microsphere sizes in a clinical setting
Findings may guide future research on the most effective embolic materials for prostate artery procedures

Resumen

This is the first systematic comparison between the smallest and the second smallest commercially available TGM sizes in the clinical context of PAE. These findings may help guide ongoing research to identify the most appropriate embolic material for PAE.

Me gusta

Guardar

Ver artículo completo